January 9, 2020 / 6:06 AM / 18 days ago

BRIEF-Newron Starts Clinical Trial With Evenamide In Schizophrenia Patients

Jan 9 (Reuters) - NEWRON PHARMACEUTICALS SPA:

* ANNOUNCES INITIATION OF NEW CLINICAL TRIAL WITH EVENAMIDE IN PATIENTS WITH SCHIZOPHRENIA, FOLLOWING APPROVAL OF PLAN BY FDA

* EXPECTS INITIAL RESULTS FROM ADDITIONAL STUDIES IN RATS AND HUMANS IN Q3 2020

* WE EXPECT TO SUBMIT INITIAL RESULTS TO FDA IN Q3 2020, AND RESULTS FROM NEXT STUDY IN PATIENTS IN Q4 2020

* ACCEPTANCE OF RESULTS FROM STUDIES IN HUMANS AND TOXICOLOGY STUDIES TO ALLOW TO START PHASE III CLINICAL PROGRAM SHORTLY THEREAFTER Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below